Free Trial

PureTech Health (LON:PRTC) Shares Down 15.2% - Time to Sell?

PureTech Health logo with Medical background

Shares of PureTech Health plc (LON:PRTC - Get Free Report) fell 15.2% on Wednesday . The stock traded as low as GBX 117.20 ($1.53) and last traded at GBX 117.20 ($1.53). 42,764,352 shares were traded during mid-day trading, an increase of 2,645% from the average session volume of 1,557,904 shares. The stock had previously closed at GBX 138.20 ($1.81).

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group reissued a "buy" rating and set a GBX 455 ($5.95) price objective on shares of PureTech Health in a research report on Monday, December 16th.

Check Out Our Latest Analysis on PRTC

PureTech Health Stock Up 6.6 %

The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 45.82. The stock has a market capitalization of £377.88 million, a PE ratio of -5.16 and a beta of 1.02. The company's fifty day moving average price is GBX 135.24 and its 200-day moving average price is GBX 148.09.

About PureTech Health

(Get Free Report)

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.

Read More

Should You Invest $1,000 in PureTech Health Right Now?

Before you consider PureTech Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.

While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines